Synthesis of novel 2-arylsulfonylimino-3,4- dimethyl-5-(5-<i>S</i>-substituted [1,3,4]oxadiazol- 2-yl)-2,3-dihydrothiazole derivatives and their plant growth stimulant activity
作者:Karine A. Eliazyan、Ruzanna S. Hakobyan、Vergush A. Pivazyan、Emma A. Ghazaryan、Siranush V. Harutyunyan、Aleksandr P. Yengoyan
DOI:10.1515/hc-2013-0055
日期:2013.8.1
two-step synthesis. Heterocyclization of the hydrazide moiety yielded 2-arylsulfonylimino-3,4-dimethyl-5-(5-thioxo-4,5-dihydro-[1,3,4]oxadiazol-2-yl)-2,3-dihydro-thiazoles 3. Treatment of compounds 3 with various alkyl halides gave corresponding S-substituted derivatives 4–6. The plant growthstimulantactivities of synthesized compounds were compared with those of similar [1,2,4]triazol- and [1,3,4,]th
Bifunctional ethyl 2-amino-4-methylthiazole-5-carboxylate derivatives: Synthesis and in vitro biological evaluation as antimicrobial and anticancer agents
作者:Sherif A.F. Rostom、Hassan M. Faidallah、Mohammed F. Radwan、Mona H. Badr
DOI:10.1016/j.ejmech.2014.02.027
日期:2014.4
Thirty thiazole compounds bearing chemotherapeutically-active pharmacophores were synthesized and evaluated for their preliminary in vitro antimicrobial and anticancer activities. Nineteen compounds displayed obvious antibacterial potential, with special bactericidal activity against Gram positive bacteria, whereas, nine analogs showed moderate to weak antifungal activity against Candida albicans. The analog 12f proved to be the most active antimicrobial member identified in this study being comparable to ampicillin and gentamicin sulfate against Staphylococcus aureus and Bacillus subtilis, together with a moderate antifungal activity. Additionally, nine derivatives were tested for their preliminary in vitro anticancer activity according to the current one-dose protocol of the NCI. Compound 9b revealed a broad spectrum of anticancer activity against 29 out of the tested 60 subpanel tumor cell lines. Collectively, compounds 4, 9b, 10b and 12f could be considered as promising dual anticancer antibiotics. (C) 2014 Elsevier Masson SAS. All rights reserved.